Similarly, HSPB8 can act either as a tumor-promoting or tumor-suppressive factor depending on cancer type and mutational background [68,69], suggesting that differential pathway activation, feedback loops, and cell-type–specific metabolic or epigenetic states may underlie these contrasting effects. Here, HSPB8 is linked to cancer.